Broadfin Capital’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-477,607
| Closed | -$6.21M | – | 53 |
|
|
2018
Q1 | $6.21M | Buy |
477,607
+71,400
| +18% | +$928K | 0.97% | 32 |
|
|
2017
Q4 | $7.27M | Hold |
406,207
| – | – | 1.19% | 23 |
|
|
2017
Q3 | $10.2M | Buy |
406,207
+129,187
| +47% | +$3.24M | 1.51% | 19 |
|
|
2017
Q2 | $6.68M | Buy |
277,020
+53,158
| +24% | +$1.28M | 0.81% | 28 |
|
|
2017
Q1 | $4.31M | Sell |
223,862
-562,272
| -72% | -$10.8M | 0.52% | 35 |
|
|
2016
Q4 | $12.1M | Hold |
786,134
| – | – | 1.34% | 22 |
|
|
2016
Q3 | $10.2M | Sell |
786,134
-17,198
| -2% | -$224K | 0.92% | 31 |
|
|
2016
Q2 | $11.2M | Buy |
803,332
+273,050
| +51% | +$3.8M | 1.09% | 25 |
|
|
2016
Q1 | $8.04M | Sell |
530,282
-1
| -0% | -$15 | 0.78% | 30 |
|
|
2015
Q4 | $10.1M | Hold |
530,283
| – | – | 0.62% | 40 |
|
|
2015
Q3 | $10.1M | Hold |
530,283
| – | – | 0.56% | 43 |
|
|
2015
Q2 | $13.7M | Buy |
530,283
+270,000
| +104% | +$6.96M | 0.73% | 37 |
|
|
2015
Q1 | $8.14M | Hold |
260,283
| – | – | 0.63% | 43 |
|
|
2014
Q4 | $8.03M | Buy |
+260,283
| New | +$8.03M | 0.7% | 39 |
|